Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study).
Sung-Yong ChoSeong Jin JeongSangchul LeeJang Hwan KimSeong Ho LeeMin Soo ChooSeung June OhPublished in: Neurourology and urodynamics (2021)
Mirabegron was effective in treating OAB symptoms in patients with Parkinsonism with acceptable adverse events.